HCTI vs TIVC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HCTI presents a classic value trap scenario, characterized by a stable Piotroski F-Score of 4/9 but catastrophic price action and fundamental decay. While the company shows strong top-line revenue growth of 44.6%, it is coupled with a disastrous ROE of -183% and an operating margin of -74.26%. The extreme discrepancy between the 52-week high ($7470) and current price ($2.40) indicates a total collapse in investor confidence or a massive corporate restructuring. Despite low debt and a healthy current ratio, the lack of profitability and negative earnings surprises make this a high-risk speculative asset.
TIVC exhibits severe financial distress, anchored by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. Despite a high current ratio suggesting short-term liquidity, the company is experiencing a catastrophic collapse in revenue (-267.78% Q/Q) and a near-total loss of shareholder value over a 5-year horizon (-100%). While the stock trades at a deep discount to book value (P/B 0.17), the lack of profitability and negative ROE (-82.69%) suggest a value trap rather than a value opportunity.
Compare Another Pair
Related Comparisons
HCTI vs TIVC: Head-to-Head Comparison
This page compares Healthcare Triangle, Inc. (HCTI) and Tivic Health Systems, Inc. (TIVC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.